News

The derivation process covered by the patent offers a means for commercial scale manufacturing of an allogeneic, off-the-shelf immunotherapy platform. Advanced Cell Technology president and chief executive officer

On August 13, 2014, Novartis AG filed a lawsuit against Breckenridge in the United States District Court for the District of Delaware. Breckenridge submitted its Paragraph IV ANDA

The US Food and Drug Administration (FDA) had granted clearance for Mylan’s abbreviated new drug application (ANDA) for this product, which is indicated to treat osteoporosis in postmenopausal

Under the deal, Meiji will start promotional activities for Rozerem on 01 October, targeting psychiatric institutions covered by MRs fully dedicated to the CNS field. Currently, the melatonin

Specifically, results from this study of 20 healthy adults demonstrated that the mean time to peak plasma concentration following administration of a single 900mg dose of delafloxacin was

SGX301 is poised to enter pivotal Phase 3 clinical testing for the treatment of cutaneous T-cell lymphoma (CTCL) and is highly synergistic with the company’s existing development pipeline.

As agreed with FDA, ceftazidime-avibactam was submitted as a 505(b)(2) NDA for the treatment of patients with cIAI and cUTI based on the efficacy and safety of ceftazidime,

The addition of BONINE provides significant scale to its U.S.OTC nausea franchise. Its EMETROL brand is the #1 pharmacist recommended nausea remedy, and has provided consumers with relief

These two are life-threatening fungal infections predominantly occurring in immunocompromised patients. The FDA has designated the date of 8 March 2015 for the completion of the review, in